Rammensee HG - Search Results

1

High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules.

Moritz A, Anjanappa R, Wagner C, Bunk S, Hofmann M, Pszolla G, Saikia A, Garcia-Alai M, Meijers R, Rammensee HG, Springer S, Maurer D. Moritz A, et al. Among authors: rammensee hg. Sci Immunol. 2019 Jul 19;4(37):eaav0860. doi: 10.1126/sciimmunol.aav0860. Sci Immunol. 2019. PMID: 31324691

2

Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.

Vogt AB, Kropshofer H, Kalbacher H, Kalbus M, Rammensee HG, Coligan JE, Martin R. Vogt AB, et al. Among authors: rammensee hg. J Immunol. 1994 Aug 15;153(4):1665-73. J Immunol. 1994. PMID: 7519208

3

Analysis of a naturally occurring HLA class I-restricted viral epitope.

Falk K, Rötzschke O, Stevanović S, Gnau V, Sparbier K, Jung G, Rammensee HG, Walden P. Falk K, et al. Among authors: rammensee hg. Immunology. 1994 Jul;82(3):337-42. Immunology. 1994. PMID: 7525458 Free PMC article.

4

MHC molecules as peptide receptors.

Rammensee HG, Falk K, Rötzschke O. Rammensee HG, et al. Curr Opin Immunol. 1993 Feb;5(1):35-44. doi: 10.1016/0952-7915(93)90078-7. Curr Opin Immunol. 1993. PMID: 7680871 Review.

5

Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.

Malcherek G, Falk K, Rötzschke O, Rammensee HG, Stevanović S, Gnau V, Jung G, Melms A. Malcherek G, et al. Among authors: rammensee hg. Int Immunol. 1993 Oct;5(10):1229-37. doi: 10.1093/intimm/5.10.1229. Int Immunol. 1993. PMID: 8268130

6

Protein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum.

Lammert E, Stevanović S, Brunner J, Rammensee HG, Schild H. Lammert E, et al. Among authors: rammensee hg. Eur J Immunol. 1997 Jul;27(7):1685-90. doi: 10.1002/eji.1830270714. Eur J Immunol. 1997. PMID: 9247578

7

Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.

Fisch P, Meuer E, Pende D, Rothenfusser S, Viale O, Kock S, Ferrone S, Fradelizi D, Klein G, Moretta L, Rammensee HG, Boon T, Coulie P, van der Bruggen P. Fisch P, et al. Among authors: rammensee hg. Eur J Immunol. 1997 Dec;27(12):3368-79. doi: 10.1002/eji.1830271236. Eur J Immunol. 1997. PMID: 9464825

8

The making of the dominant MHC class I ligand SYFPEITHI.

Dick TP, Stevanović S, Keilholz W, Ruppert T, Koszinowski U, Schild H, Rammensee HG. Dick TP, et al. Among authors: rammensee hg. Eur J Immunol. 1998 Aug;28(8):2478-86. doi: 10.1002/(SICI)1521-4141(199808)28:08<2478::AID-IMMU2478>3.0.CO;2-U. Eur J Immunol. 1998. PMID: 9710225 Free article.

9

Cell lines transfected with the TAP inhibitor ICP47 allow testing peptide binding to a variety of HLA class I molecules.

Gatfield J, Lammert E, Nickolaus P, Münz C, Rothenfusser S, Fisch P, Stevanović S, Schild H, Rammensee HG, Arnold D. Gatfield J, et al. Among authors: rammensee hg. Int Immunol. 1998 Nov;10(11):1665-72. doi: 10.1093/intimm/10.11.1665. Int Immunol. 1998. PMID: 9846695

10

Alloreactivity as a source of high avidity peptide-specific human CTL.

Münz C, Obst R, Osen W, Stevanović S, Rammensee HG. Münz C, et al. Among authors: rammensee hg. J Immunol. 1999 Jan 1;162(1):25-34. J Immunol. 1999. PMID: 9886366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters